abs213.txt	epstein-barr	virus	(ebv)	zebra	protein	activates	the	ebv	lytic	cycle		cellularap-1	proteins	with	alanine-to-serine	[ap-1(a/s)]	substitutions	homologous	tozebra(s186)	assume	some	functions	of	these	ap-1(a/s)	mutants	bindmethylated	dna	and	activate	expression	genes	here	we	compareexpression	67	viral	induced	by	versus	byap-1(a/s)	activated	24	to	high	levels	15	tointermediate	activation	28	was	severely	impaired	show	that	are	defective	at	stimulating	dnareplication	impairment	many	late	compared	ofzebra	is	likely	due	inability	promote	however	even	in	absence	detectable	replication	stimulated	a	subgroup	encodeviral	structural	immune	modulators	response	expressionof	this	inhibited	phosphonoacetic	acid	(paa)	whichis	potent	inhibitor	when	wasactivated	paa	did	not	reduce	lategenes	also	provide	genetic	evidence	using	bmrf1	knockout	bacmid	thatthese	true	binds	thepromoter	region	least	one	bdlf3	encoding	an	immunemodulator	importance	mutant	c-jun	c-fos	selectively	activateexpression	including	theabsence	findings	indicate	newly	synthesizedviral	invariably	required	for	gene	while	viraldna	may	be	obligatory	driven	viraltranscription	factors	it	does	limit	ability	cellular	transcriptionfactors	our	results	thatexpression	all	strictly	dependent	on	a151s	mutation	has	been	identified	human	cancer	combination	wild-type	data	proof	principle	transcription	factorscould	cause	aberrant	regulation	playimportant	roles	ebv-associated	diseases
